Business
Supreme Critical Metals Announces Closing of Second and Final Tranche of LIFE Offering
Vancouver, British Columbia--(Newsfile Corp. - February 17, 2026) - Supreme Critical Metals Inc. (CSE: CRIT) ("Supreme" or the "Company") is pleased to announce it has closed the final tranche of its non-brokered private placement (the "LIFE Offering") financing of up to 14,000,000 units of the Company ("Units") as previously announced in its press release dated February 6, 2026 (the "Initial Press Release") and upsized on February 6, 2026 as announced by the Company. Any words capitalized but..
About this update from Supreme Critical Metals Inc
[{"type":"text","content":"Vancouver, British Columbia--(Newsfile Corp. - February 17, 2026) - Supreme Critical Metals Inc. (CSE: CRIT) ("Supreme" or the "Company") is pleased to announce it has closed the final tranche of its non-brokered private placement (the "LIFE Offering") financing of up to 14,000,000 units of the Company ("Units") as previously announced in its press release dated February 6, 2026 (the "Initial Press Release") and upsized on February 6, 2026 as announced by the Company. Any words capitalized but undefined herein shall have the meaning ascribed to such capitalized term in the Initial Press Release.","length":652,"tagName":"p"},{"type":"text","content":"The second and final tranche closing of the LIFE Offering consisted of the issuance of an aggregate of 1,730,000 Units at a price of $0.10 per Unit. Each Unit consists of one Common Share and one-half of one common share purchase warrant (a "Warrant"). Each whole Warrant will entitle the holder thereof to acquire one additional Common Share in the capital of the Company at a price of $0.20 for a period of 24 months from the closing of the second tranche of the LIFE Offering.","length":489,"tagName":"p"},{"type":"text","content":"The LIFE Offering resulted in the issuance of a total of 11,410,000 Units and a raise of gross aggregated proceeds to the Company of $1,141,000. The LIFE Offering was oversubscribed from the originally announced maximum of 10,000,000 Units at a rate of 114.1%.","length":260,"tagName":"p"},{"type":"text","content":"The Company relied on the listed issuer financing exemption under Part 5A of National Instrument 45-106 - Prospectus Exemptions in connection with the distribution of all 1,730,000 free trading Common Shares under this final tranche of the LIFE Offering for proceeds of $173,000. The Company paid $2,130 in finder's fees and issued 23,100 finder's warrants (the "Finder's Warrants") in connection with this tranche of the LIFE Offering. The Finder's Warrants entitle the holder thereof to acquire one additional Common Share in the capital of the Company at a price of $0.20 for a period of 24 months from the closing of the second tranche of the LIFE Offering.","length":687,"tagName":"p"},{"type":"text","content":"Closing of the LIFE Offering was conditionally approved by...